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A hierarchical hematopoietic development with
myeloid versus lymphoid bifurcation has been
proposed downstream of the multipotent pro-
genitor (MPP) stage, based on prospective iso-
lation of progenitors capable of generating only
myeloerythroid cells (common myeloid progeni-
tor, CMP) or only lymphocytes (common lym-
phoid progenitor, CLP). By utilizing GATA-1 and
PU.1 transcription factor reporters,herewe iden-
tified progenitor populations that are precursors
for either CMPs or CLPs. Two independent
populations expressing either GATA-1 or PU.1
resided within the CD34+Sca-1+c-Kit+ MPP frac-
tion. The GATA-1+ MPP displayed potent mye-
loerythroid potential without giving rise to lym-
phocytes, whereas the PU.1+ MPP showed
granulocyte/monocyte/lymphoid-restrictedpro-
genitor activity without megakaryocyte/ery-
throid differentiation. Furthermore, GATA-1+
andPU.1+MPPspossessedhugeexpansionpo-
tential and differentiated into the original CMPs
and CLPs, respectively. Thus, the reciprocal ac-
tivation of GATA-1 and PU.1 primarily organizes
the hematopoietic lineage fate decision to form




Understanding how multipotent cells commit to each of
their terminal fate potentials is an important aspect of
stem cell biology. Lineage commitment pathways from
hematopoietic stem cells (HSCs) (Spangrude et al.,
1991) have been proposed dependent upon the existence416 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Incof prospectively isolatable lineage-restricted progenitor
populations (Akashi et al., 2005; Morrison et al., 1995). In
adult murine hematopoiesis, HSCs with long-term (LT)
self-renewal potential reside within the LinSca-1+c-Kit+
(LSK) fraction having CD34 (Osawa et al., 1996), Thy1lo
(Morrison and Weissman, 1994), and Flt3/Flk2 (Adolfs-
son et al., 2001; Christensen and Weissman, 2001) pheno-
types. The LSK cells having CD34+, Thy1, and/or Flt3+
phenotypes are capable of multilineage reconstitution
only for a short term and therefore should contain multipo-
tent progenitors (MPPs) (Christensen and Weissman,
2001; Iwasaki and Akashi, 2007; Osawa et al., 1996).
There has been a controversy in terms of developmental
steps downstream of MPPs (Iwasaki and Akashi, 2007).
One model suggests that myeloerythroid and lymphoid
developmental pathways are largely independent based
on the fact that the earliest myeloid and lymphoid progen-
itors such as the common myeloid progenitor (CMP) (Aka-
shi et al., 2000) and the common lymphoid progenitor
(CLP) (Kondo et al., 1997) are prospectively isolatable out-
side the LSK fraction. CMPs gave rise to all myeloerythroid
cells via developmental intermediates such as the granu-
locyte/monocyte progenitor (GMP) and the megakaryo-
cyte/erythrocyte progenitor (MEP) (Akashi et al., 2000),
while CLPs are precursors for all lymphoid cells including
T, B, and NK cells (Kondo et al., 1997).
Recently, however, several studies have suggested that
lineage commitment could occur at the MPP stage, pre-
ceding the proposed bifurcation of myeloid and lymphoid
pathways. The MPP population contains a fraction of cells
expressing the lymphoid lineage-specific recombination
activation gene (rag)-1, called the earliest lymphoid pro-
genitor (ELP), which differentiate mainly into lymphoid
cells but retain a minor myeloid potential (Igarashi et al.,
2002). Another study showed that a fraction of MPP ex-
pressing Flt3, especially at a high level, does not have
megakaryocyte/erythroid (MegE) potential, if any, and is
largely primed for the lymphoid lineage. The Flt3+ MPP
was therefore termed as the lymphoid-primed multipotent
progenitor (LMPP) (Adolfsson et al., 2005). Because the.
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loss of self-renewal activity and MegE potential in the early
HSC commitment has been proposed (Adolfsson et al.,
2005). Based on this finding, GM cells could develop with-
out passing through the CMP stage, and the LMPP could
be the major pathway for GM cells (Adolfsson et al., 2005).
More recently, however, Forsberg et al. reported that the
Flt3+ LMPP population possesses robust MegE potential,
represented by their ability to produce a significant num-
ber of erythroid cells and platelets at a relatively late phase
after transplantation (day 12–15), claiming that the CMP
and the CLP still constitute the major site for myeloid ver-
sus lymphoid lineage decision (Forsberg et al., 2006).
How can we reconcile the controversy in the early he-
matopoietic lineage map? Because uncommitted cells
prime multiple lineage-affiliated developmental programs
at the single-cell level prior to lineage commitment (Hu
et al., 1997), the major question here is whether the GM
development program is coprimed with the MegE pro-
gram at the CMP stage, with the lymphoid program at
the LMPP stage, or both. In fact, in previous single-cell
PCR studies, a considerable fraction of single CMPs and
LMPPs possess GM and MegE, and GM and lymphoid
gene transcripts, respectively (Mansson et al., 2007; Miya-
moto et al., 2002). The problem is that the CMP and the
LMPP are still functionally heterogenous populations:
the remaining MegE potential in the LMPP (Forsberg
et al., 2006) raises a possibility that the LMPP contains
populations with MegE potential such as MPPs, whereas
CMPs possess a weak B cell potential (Akashi et al., 2000),
suggesting contamination of B cell precursors. Thus, it is
critical to test whether progenitor populations more strictly
restricted to the GM and lymphoid lineage (granulocyte/
monocyte/lymphoid progenitors, GMLP) or the CMP lack-
ing lymphoid potential could be isolated in pure form in
early hematopoiesis. In addition, it is also important to
evaluate whether such populations have significant ex-
pansion potential sufficient to play a role in maintaining
homeostasis of normal hematopoiesis (Spangrude, 2002).
Hematopoietic development models have been pro-
posed simply by placing known lineage-specific progeni-
tors in a hierarchical order, which are separated based on
the difference in the expression level of antigens that may
not have significant functions in lineage fate decision (i.e.,
Sca-1, CD34, Thy-1, and Flt3). One of reasonable ap-
proaches for separating functionally distinct populations
may include the utilization of markers closely associated
with lineage-instructive signaling. In establishing lineage
diversities, antagonistic or cooperative effects of multiple
transcription factors, called a ‘‘transcription factor net-
work’’ (Orkin, 2000; Sieweke and Graf, 1998), might be
critical. The Ets family transcription factor PU.1 (Spi-1) is
one of the most important regulators of GM and lymphoid
lineage development (Rosenbauer and Tenen, 2007) and
is necessary for both HSC self-renewal and its generation
of early GM and lymphoid progenitors such as CMPs,
GMPs, and CLPs (Iwasaki et al., 2005b). GATA-1 is an es-
sential transcription factor for MegE development (Fuji-
wara et al., 1996). Importantly, PU.1 and GATA-1 can exertCeinstructive signals for GM and MegE lineage commitment,
respectively (Heyworth et al., 2002; Iwasaki et al., 2003;
Kulessa et al., 1995; Nerlov and Graf, 1998b). Further-
more, PU.1 and GATA-1 mutually inhibit each other’s ex-
pression and transactivation functions (Nerlov and Graf,
1998a; Nerlov et al., 2000; Rekhtman et al., 1999; Walsh
et al., 2002; Zhang et al., 1999, 2000). Thus, there is a gen-
eral agreement that the antagonistic interplay of PU.1 and
GATA-1 plays a critical role in early hematopoietic fate
decision such as the GM or lymphoid versus the MegE
lineage commitment (Iwasaki and Akashi, 2007).
These data led us to hypothesize that tracking the ex-
pression profile of PU.1 and GATA-1 in early hematopoie-
sis may provide critical data on developmental pathways
of each lineage. By utilizing mice having GATA-1 or PU.1
transcriptional reporters, we here present a high-resolu-
tion map containing lineage-restricted progenitor popula-
tions within the MPP population of CD34+ LSK phenotype.
We found that MPPs upregulating either PU.1 or GATA-1
are functional GMLPs or CMPs, respectively. PU.1+
GMLPs gave rise to the CLP (Kondo et al., 1997) and the
GMP, while GATA-1+ CMPs generated the original CMP.
Accordingly, this model allows flexibility for GM develop-
ment, as the GMP can be generated via either the GMLP
or the CMP stages. The proposed hematopoietic develop-
mental scheme including these new oligopotent progeni-
tor populations reasonably reconciles a number of current
controversies in early hematopoietic development.
RESULTS
Initial Upregulation of PU.1 and GATA-1
Independently Occurs at the CD34+ LSK Stage
We first evaluated the expression of PU.1 or GATA-1 in pu-
rified conventional stem and progenitor fractions (Akashi
et al., 2000; Kondo et al., 1997; Osawa et al., 1996; Span-
grude et al., 1988). To this end, we used mice harboring
the enhanced green fluorescent protein (GFP) knocked
into the PU.1 locus (Back et al., 2004) and the transgenic
GATA-1 reporter tagged with GFP (Iwasaki et al., 2005a).
In these mouse lines, the level of GFP is correlated with
the PU.1 or GATA-1 protein level (Back et al., 2005; Iwa-
saki et al., 2005a). Figure 1A shows the expression of
GFP in stem and progenitor cells purified from PU.1GFP/+
mice. LSK cells are composed of CD34 and CD34+ pop-
ulations that are defined as the LT-HSC and the MPP, re-
spectively (Osawa et al., 1996). The vast majority of LSK
cells expressed a low level of PU.1-GFP, as we and others
have reported (Iwasaki et al., 2005b; Nutt et al., 2005). In
the myeloerythroid pathway, the GFP level progressively
increased as the MPP steps forward into the GMP stage,
while it decreased at the MEP stage. In the lymphoid path-
way, PU.1-GFP was upregulated in CLPs (Figure 1A), proT
and proB cells (data not shown). The pattern of GFP ex-
pression was reversed in GATA-1-GFP reporter mice
(Figure 1B). GATA-1-GFP was expressed in only a minority
of the LSK population but upregulated along the MegE
pathway. MEPs expressed a high level of GFP andll Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Inc. 417
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The Earliest Hematopoietic Stem Cell CommitmentFigure 1. The Expression of the PU.1-GFP or the GATA-1-GFP Reporters within the LinSca-1+c-Kit+ HSC Fraction
(A) The expression of GFP in the LSK fraction of bone marrow cells in PU.1GFP/+ mice. Note that the upregulation of PU.1-GFP is found only in the
CD34+Flt3+ LSK fraction (left panels). PU.1-GFP is upregulated in GMPs and CLPs, but not in MEPs (right panels).
(B) The expression of GFP in GATA-1-GFP reporter mice. GATA-1-GFP is detectable in the CD34+ MPPs and is further upregulated toward the MEP
stage.
(C) The expression of RAG1-GFP within the LSK population. RAG1-GFP+ cells are seen within CD34+ MPPs, which correspond to previously defined
ELPs (Igarashi et al., 2002).
(D) The control analysis of wild-type C57BL/6 mice. Representative FACS plots of more than ten mice (6–8 weeks old) analyzed in each group are
shown.CMPs expressed negative-to-low levels of GFP, whereas
GMPs and CLPs were negative for GFP. Thus, the expres-
sion pattern of PU.1 and GATA-1 in early hematopoiesis
appeared to be reciprocal, as expected.
We next evaluated the expression pattern of Flt3 and of
PU.1 and GATA-1 reporters within the LSK fraction. Murine
LT-HSCs do not express Flt3 (Adolfsson et al., 2001; Chris-
tensen and Weissman, 2001). In normal C57BL6 mice,
CD34 LT-HSCs were Flt3, while a fraction of CD34+
MPPs upregulated Flt3 at a high level (Figure 1D), forming
the LMPP population (Adolfsson et al., 2005). In PU.1GFP/+
mice, LT-HSCs were entirely Flt3and PU.1-GFPlo (PU.1lo)
(Figure 1A). In MPPs, a high level of PU.1-GFP (PU.1+) was
seen only in a fraction of cells with a high level of Flt3,
suggesting that this population represents the earliest he-
matopoietic stage initiating PU.1 upregulation. In GATA-1-
GFP reporter mice (Figure 1B), LT-HSCs were all Flt3 and
GFP. In marked contrast to GFP expression in PU.1GFP/+
mice, GATA-1-GFP+ (GATA-1+) cells were found only in
a fraction of MPPs that do not express Flt3 (Figure 1B).
Thus, the initial upregulation of PU.1 or GATA-1 occurs in-
dependently at the MPP stage in Flt3+ or Flt3 subpopula-418 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Inctions, respectively. In RAG1+/GFP mice (Kuwata et al., 1999)
(Figure 1C), GFP was expressed in a fraction of MPPs ex-
pressing a high level of Flt3. The Flt3+ MPPs expressing
RAG1-GFP (RAG1+) correspond to previously defined
ELPs (Igarashi et al., 2002). This population was largely
committed to the lymphoid lineage retaining weak GM po-
tential (see Figure S1A in the Supplemental Data available
with this article online). These data indicate that both PU.1+
MPPs and RAG1+ ELPs reside within the LMPP
population.
Figure 2A shows the quantitative real-time PCR analysis
of PU.1 and GATA-1 mRNA in purified MPP subpopula-
tions. In PU.1GFP/+ mice (upper panels), LT-HSCs and
PU.1lo MPPs had a similar low level of PU.1 transcript,
whereas PU.1 + MPPs possessed an 2-fold higher level
of PU.1 transcripts as compared to those in PU.1lo MPPs.
In all of these subpopulations, GATA-1 transcripts were
below the measurable level. CLPs expressed PU.1 at
a level similar to that of PU.1+ MPPs. The PU.1 mRNA level
progressively increased along the GM differentiation path-
way: CMPs and GMPs expressed 5- and 8-fold higher
levels of PU.1 transcripts as compared to those in PU.1lo.
Cell Stem Cell
The Earliest Hematopoietic Stem Cell CommitmentFigure 2. The Expression Level of PU.1 mRNA, GATA-1 mRNA, and Sca-1 Antigen in the PU.1-GFP- or GATA-1-GFP-Based LSK
Subfractions
(A) Quantitative real-time PCR assays of PU.1 and GATA-1 mRNA in stem and progenitors purified from PU.1GFP/+ or GATA-1-GFP mice. PCR
reactions were triplicated and performed at least twice. Data were compensated with the internal control b2-MG value and shown as mean ± standard
deviation (error bars).
(B) The analysis of the expression levels of Sca-1 in the LSK subpopulations. Both PU.1+ and GATA-1+ MPPs express Sca-1 at a lower level as
compared to that of LT-HSCs. Representative FACS plots from three mice analyzed are shown.MPPs, respectively. In contrast, MEPs did not express
a measurable level of PU.1 mRNA but had a high level of
GATA-1 mRNA.
In GATA-1-GFP mice (bottom panels), GATA-1 mRNA
was not found in the LT-HSCs or GATA-1 MPPs, while
GATA-1+ MPPs had a considerable level of GATA-1 tran-
scripts whose levels were almost equal to those in CMPs.
Interestingly, GATA-1+ MPPs possessed an almost 4-fold
lower level of PU.1 mRNA as compared to that in GATA-1
MPPs. MEPs possessed GATA-1 transcript at a level 6-
fold higher than that in GATA-1+ MPPs, whereas GMP or
CLPs did not express GATA-1. Thus, the levels of PU.1
or GATA-1 mRNA fairly corresponded to the GFP levels
in each subpopulation, and the expression patterns of
PU.1 and GATA-1 mRNA were generally reciprocal during
hematopoietic development, consistent with the previous
finding that transcription of PU.1 and GATA-1 genes is
mutually exclusive.CellUpregulation of PU.1 andGATA-1within theCD34+
LSK Stage Occurs with Decrease in the
Expression Level of Sca-1
The ‘‘gold standard’’ definition for murine HSC is the
‘‘LSK’’ (Ikuta and Weissman, 1992; Osawa et al., 1996),
while the myeloid progenitors such as CMPs, GMPs,
and MEPs were defined within the LinSca-1c-Kit+ pop-
ulation (Akashi et al., 2000), suggesting that Sca-1 is grad-
ually downregulated during the early phase of myeloeryth-
roid commitment. We thus carefully evaluated the
expression level of Sca-1 in PU.1+ and GATA-1+ MPPs.
In both PU.1GFP/+ and GATA-1-GFP reporter mice, LT-
HSCs expressed Sca-1 at the highest level (Figure 2B).
Notably, the PU.1+ and GATA-1+ MPP populations did
not express a high level of Sca-1 but expressed Sca-1
only at a low level (Sca-1lo). These data clearly show that
the upregulation of either PU.1 or GATA-1 within the LSK
fraction occurs along with the decline in the level of Sca-1.Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Inc. 419
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The Earliest Hematopoietic Stem Cell CommitmentFigure 3. PU.1+ MPPs Possess Differentiation Potential Restricted to the GM and the Lymphoid Lineages
(A) Clonogenic myeloerythroid colony assays for LSK subfractions in PU.1GFP/+ mice. Types of colonies were determined morphologically and
cytochemically by May-Giemsa staining.
(B) Limiting dilution analyses of B or T cell potential tested on the OP9 or the OP9-DL1 stromal cell layer, respectively. Both PU.1lo and PU.1+ MPPs
differentiated into B and T cells at a similar frequency.
(C) In vivo reconstitution potential of LSK subfractions in PU.1GFP/+ mice. Percentages of donor-derived cells in blood leukocytes from two represen-
tative recipients per group of five mice are shown. PU.1+ MPPs displayed significant but transient reconstitution for GM, B, and T cells.PU.1+MPPs LackMegE Potential but Possess GM-
and Lymphoid-Restricted Differentiation Potential
We evaluated the differentiation potential of PU.1+ MPPs.
Single cells from each LSK subfraction based on CD34
and PU.1 expression gave rise to colonies at high plating
efficiencies (>95%) in vitro (Figure 3A). LT-HSCs gave
rise to a variety of myeloerythroid colonies. Within the
MPP population, Flt3+ LMPP gave rise mainly to GM col-
onies with only a few percent of MegE colonies, consistent
with the previous report that the exclusion of MegE lineage
potential has already started with the upregulation of Flt3
(Adolfsson et al., 2005). PU.1+ MPPs formed only GM col-
onies, suggesting that the vast majority of them have lost
MegE potential. Purified PU.1lo or PU.1+ MPPs were then
cultured in vitro on OP9 or OP9-DL1 stromal layers to test
B or T cell potential, respectively. As shown in Figure 3B,
both populations gave rise to B and T cells at similar high
frequencies, indicating that the lymphoid potential is pre-
served during the upregulation of PU.1 within the MPP420 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Instage. Around 80% of CD34+Flt3+ LSK cells possessed
clonogenic GM/T/B potential in vitro (Adolfsson et al.,
2005). We also found that at least >20% of single PU.1+
MPPs (Ly5.2) gave rise to GM, T, and B cells when they
were injected directly into the congenic (Ly5.1) thymi
(Figure S1B).
We then transplanted 500 cells each of LT-HSC, PU.1lo
MPP, and PU.1+ MPP populations (Ly5.2) into congenic
hosts (Ly5.1) competitively with 300 recipient-type LSK
cells (Ly5.1). LT-HSCs displayed strong and LT multiline-
age reconstitution activity, as expected (Figure 3C). Re-
constitution by PU.1lo MPPs was observed only for a short
term. Percentages of donor-derived cells reached >80%
at peaks in all GM, B, and T cell lineages at 3, 6, and 12
weeks posttransplantation, respectively, but all of these
lineage cells progressively decline thereafter. PU.1+
MPPs displayed transient reconstitution that was even
shorter than that by PU.1lo MPPs. The peak percentages
of GM and B cell progeny were seen at 3 weeksc.
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The Earliest Hematopoietic Stem Cell CommitmentFigure 4. PU.1+ MPPs Lack MegE Potential In Vivo
(A) The absolute number of Ter119+ erythroid progeny in the spleen 12 days after injection of 1000 cells each of PU.1lo and PU.1+ MPPs. Represen-
tative data of an experiment containing three recipients per group are shown as mean ± standard deviation (error bars).
(B) A fraction of platelets expressed the YFP reporter in gpIIb+/YFP mice.
(C) The analysis of donor-derived platelets, GM cells, and B cells after injection of 500 cells each of PU.1lo and PU.1+ MPPs purified from gpIIb+/YFP3
PU.1GFP/+ mice. Analyses were performed 15 days after transplantation. Two representative recipients per group of ten mice are shown.posttransplantation, while donor-derived T cells reached
a peak at 6 weeks posttransplantation. Donor-type
spleen TER119+ erythroid cells were found 1 or 2 weeks
after transplantation in mice injected with LT-HSCs or
PU.1lo MPPs, but not in mice with PU.1+ MPPs at these
time points (data not shown). These data collectively sug-
gest that the PU.1+ MPP possesses the GM/lymphoid-re-
stricted lineage potential.
We further evaluated the MegE activity of these popu-
lations. One thousand PU.1lo and PU.1+ MPPs were
transplanted into lethally irradiated hosts, and the abso-
lute number of Ter119+ erythroid cells was enumerated
in the spleen on day 12. As shown in Figure 4A, while
spleens of mice transplanted with PU.1lo MPPs had
abundant Ter119+ cells, those in mice with PU.1+ MPPs
did not contain measurable numbers of Ter119+ cells.
Because platelets do not express Ly5 antigens, Forsberg
et al. used actin-GFP mice (Wright et al., 2001) as a donor
to mark donor-derived platelets as GFP+ and showed
that LMPPs could generate significant numbers ofCeGFP+ platelets 2 weeks after transplantation (Forsberg
et al., 2006). To visualize donor-derived platelets in our
system, we crossed the PU.1GFP/+ mouse with a line har-
boring the enhanced yellow fluorescent protein (YFP)
knocked into the gpIIb locus, whose platelets possess
YFP (Schulze et al., 2006). In gpIIb+/YFP mice, almost
16% of platelets were labeled with YFP (Figure 4B).
Five hundred cells of PU.1lo or PU.1+ MPPs (Ly5.2)
were purified from PU.1GFP/+ 3 gpIIb+/YFP mice and
were injected into lethally irradiated congenic hosts
(Ly5.1). Two weeks after transplantation, 4%–6% of
platelets were labeled with YFP in mice transplanted
with PU.1lo MPPs. In contrast, YFP+ platelets were never
found in mice transplanted with PU.1+ MPPs, while GM
and B cell lineages were reconstituted at a level compa-
rable to mice with PU.1lo MPPs (Figure 4C). Thus, the
PU.1+ MPP fails to produce erythrocytes and platelets,
but it develops GM, T, and B cells at the single-cell level,
providing a formal proof that the GMLP exists within the
LMPP fraction.ll Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Inc. 421
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The Earliest Hematopoietic Stem Cell CommitmentFigure 5. GATA-1+ MPPs Possess GM and MegE but Not Lymphoid Potential
(A) Clonogenic myeloerythroid colony assays for LSK subpopulations in GATA-1-GFP mice. GATA-1+ MPPs gave rise to GM and MegE colonies in
vitro. Note that 40% of their colonies were CFU-Mix that contained both GM and MegE cells.
(B) In vivo myeloerythroid potential of LSK subfractions and progenitors. Five hundred cells each of listed populations were injected into lethally
irradiated hosts, and the absolute numbers of Ter119+ erythroid and CD11b+ GM progeny were evaluated in the spleen on days 8 and 12. Three re-
cipient mice were analyzed for each group. Results are shown as mean ± standard deviation (error bars).
(C) In vivo lymphoid potential in GATA-1 and GATA-1+ MPPs. Five hundred cells each were transplanted into congenic hosts together with 300
RAG2/ LSK (Ly5.1) cells. Absolute numbers of lymphocytes was enumerated in the spleen and the thymus on days 21, 28, and 35. GATA-1+
MPPs never gave rise to lymphocyte progeny in these time points. Four or five mice were analyzed for each experiment.GATA-1+ MPPs Lack Lymphoid Potential but
Possess a Strong Common Myeloid Progenitor
Activity
LT-HSCs are GATA-1, and a fraction of Flt3 but not
Flt3+ MPPs (LMPPs) express GATA-1-GFP (Figure 1B).
Figure 5A shows the myeloerythroid differentiation activity
of MPP subpopulations. LT-HSCs gave rise to a variety of
myeloerythroid colonies, including 20% of colonies con-
taining both MegE and GM lineage cells (CFU-Mix). Inter-
estingly, the CFU-Mix activity was most concentrated in
the GATA-1+ MPPs, in which 40% of single cells formed
mixed colonies. In vivo analyses showed that GATA-1+
MPPs possess very potent myeloerythroid potential
(Figure 5B). Purified 500 cells each of GATA-1 MPPs,
GATA-1+ MPPs, and LinSca-1c-Kit+ CMPs and MEPs
(Akashi et al., 2000) were injected into lethally irradiated
congenic hosts. On day 8, GATA-1+ MPPs produced422 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier IncTer119+ cells whose numbers were almost equal to those
from the same number of CMPs or MEPs. On day 12, how-
ever, GATA-1+ MPPs gave rise to a much higher number
of Ter119+ cells as compared to CMPs and MEPs. Fur-
thermore, although only CMPs produced a detectable
level of CD11b+ GM cells on day 8, GATA-1+ MPPs pro-
duced >20-fold higher numbers of GM cells as compared
to those from CMPs on day 12, indicating that GATA-1+
MPPs possess potent GM potential.
GATA-1+ MPPs were also cultured in vitro on OP9 or
OP9-DL1 stromal layers to test their lymphoid potential.
Repeated culture of 1000 GATA-1+ MPPs in this condition,
however, never gave rise to B or T cells (data not shown).
We then transplanted 500 cells each of GATA-1 and
GATA-1+ MPPs (Ly5.2) into congenic C57BL6 (Ly5.1)
mice competitively with 300 RAG2/ LSK cells (Ly5.1).
The number of progeny was evaluated on days 21, 28,.
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The Earliest Hematopoietic Stem Cell CommitmentFigure 6. Lineal Relationships between PU.1+ and GATA-1+ MPPs and Conventional Myeloid and Lymphoid Progenitor Popula-
tions
Short-term differentiation of PU.1+ and GATA-1+ MPPs on the OP9 stromal layer. After a 40 hr culture, cells were subjected to myeloerythroid or
lymphoid progenitor analysis.
(A) The analysis of the LinSca-1c-Kit+ fraction for the conventional myeloerythroid progenitors such as CMPs, GMPs, and MEPs (Akashi et al.,
2000). Note that PU.1+ MPPs give rise to GMPs, but not CMPs, while GATA-1+ MPPs gave rise mainly to CMPs.
(B) The analysis for cells with CLP phenotype. Note that PU.1+ MPPs, but not GATA-1+ MPPs, generated CLPs.
(C) Real-time PCR analyses for lineage-related genes in purified progenitor populations. PCR reactions were triplicated and performed at least twice.
Results are shown as mean ± standard deviation (error bars).and 35. Again, GATA-1+ MPPs did not gave rise to detect-
able numbers of T or B cells in the spleen or the thymus,
while GATA-1 MPPs progressively generated T and B
cells (Figure 5C).
Thus, at least 40% of GATA-1+ MPPs possess potent
and clonal GM and MegE potential but lack lymphoid dif-
ferentiation activity, and the appearance of GM and MegE
progeny in vivo was significantly delayed as compared to
those progeny from CMPs. These data indicate that
GATA-1+ MPPs possess strong CMP potential and also
suggest that they are upstream of the original LinSca-
1c-Kit+ CMP (Akashi et al., 2000).
The PU.1+ and the GATA-1+ MPPs Are Precursors
for Conventional Hematolymphoid Progenitors
To analyze the lineal relationship between PU.1+ or
GATA-1+ MPPs and conventional hematolymphoid pro-
genitors such as CMPs, GMPs, MEPs, and CLPs (Akashi
et al., 2000; Kondo et al., 1997), we tracked changes in sur-
face phenotype of PU.1 + or GATA-1+ MPPs in vitro. Fig-
ure 6 shows progeny from PU.1+ or GATA-1+ MPPs after
a 40 hr culture on the OP9 stromal layer.
PU.1lo MPPs and GATA-1 MPPs differentiated into all
myeloerythroid progenitors such as CMPs, GMPs, and
MEPs, as well as into CLPs (data not shown). Strikingly,
PU.1+ MPPs gave rise to GMPs, but not MEPs or CMPs
(Figure 6A), while this population also generated CLPsCel(Figure 6B), correctly reflecting their GM/lymphoid poten-
tial in vivo. In marked contrast, GATA-1+ MPPs differenti-
ated mainly into CMPs as well as small numbers of GMPs
and MEPs (Figure 6A), while they did not generate CLPs
(Figure 6B). These data directly show that the PU.1+
MPPs are immediate precursors for the original GMP
and CLP, whereas GATA-1+ MPPs are precursor for the
original LinSca-1c-Kit+ CMP.
To evaluate whether gene priming status in PU.1+ or
GATA-1+ MPPs reflects each of their lineage potential,
we performed the real-time PCR analysis of representa-
tive lineage-related genes in purified PU.1+ or GATA-1+
MPPs (Figure 6C). PU.1+ MPPs expressed GM-related
C/EBPa and GM-CSFRa transcripts, whose levels were
almost equal to the original CMPs, but did not express
a detectable level of erythropoietin receptor (EpoR).
PU.1+ MPPs also expressed a low level of lymphoid genes
including RAG1 and IL-7Ra. Thus, as in case of LMPPs
(Mansson et al., 2007), PU.1+ MPPs appear to prime
both GM and lymphoid developmental programs. This
pattern of gene expression well correlates with their GM
and lymphoid lineage-restricted potential. In contrast,
GATA-1+ MPPs expressed C/EBPa only at a low level,
as in the case of PU.1 expression in this population
(Figure 2A). They expressed GM-CSFRa, EpoR, and
GATA-2 at levels equivalent to those in the original
CMPs, whereas the lymphoid RAG1 or IL-7Ra genesl Stem Cell 1, 416–427, October 2007 ª2007 Elsevier Inc. 423
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A low level of PU.1 is expressed at the Sca-1hi LT-HSC stage. PU.1 and GATA-1 upregulation initiate at the Sca-1lo MPP stage, resulting in generation
of the GMLP and the CMP, respectively. The GATA-1+Sca-1lo CMP and the PU.1+Sca-1lo GMLP are mutually independent populations and give rise
to conventional Sca-1 CMPs and CLPs, respectively. The major CMP activity resides in the GATA-1+Sca-1lo CMP stage. Note that GMPs can de-
velop from both CMPs and GMLPs, suggesting flexible developmental capability of GM lineage cells. MPP, multipotential progenitor; CMP, common
myeloid progenitor; CLP, common lymphoid progenitor; MEP, megakaryocyte/erythrocyte progenitor; GMP, granulocyte/monocyte progenitor;
LMPP, lymphoid-primed multipotent progenitor; GMLP, granulocyte/monocyte/lymphoid progenitor.were undetectable. Thus, GATA-1+ MPPs are likely to im-
mediately respond to both myeloerythroid cytokines such
as GM-CSF and Epo but do not prime lymphoid programs
represented by RAG1 and IL-7Ra expression. These prim-
ing patterns of lineage-affiliated genes appear to reflect
their developmental potential.
DISCUSSION
In this study, by utilizing either PU.1 or GATA-1 transcrip-
tion factor reporters, we isolated hematolymphoid progen-
itor populations within the adult bone marrow LSK fraction
that was originally defined as the most primitive HSC pop-
ulation (Ikuta and Weissman, 1992; Osawa et al., 1996;
Spangrude et al., 1988). The upregulation of these tran-
scription factors was found exclusively in the CD34+
MPP fraction. The PU.1+ MPP represents the GMLP capa-
ble of reconstitution restricted to the GM and the lymphoid
lineage. On the other hand, the GATA-1+ MPP is the func-
tional CMP with clonal and robust differentiation activity for
both the GM and the MegE lineages without reading out
lymphoid differentiation. Both populations express lower
levels of Sca-1 as compared to that of LT-HSCs
(Figure 2B). Newly isolated PU.1+Sca-1lo MPPs and
GATA-1+Sca-1lo MPPs are therefore termed here as424 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier IncPU.1+Sca-1lo GMLPs and GATA-1+Sca-1lo CMPs, respec-
tively. These populations develop independently with or
without the upregulation of Flt3 within the LSK fraction. Be-
cause both the PU.1+Sca-1lo GMLP and the GATA-1+Sca-
1lo CMP possess potent in vivo expansion capability, these
progenitors should constitute critical physiological stages
for hematolymphoid development. The proposed hemato-
lymphoid developmental scheme is shown in Figure 7.
There has been a controversy regarding differentiation
activity of LMPPs (Adolfsson et al., 2005; Forsberg et al.,
2006) that express a high level of Flt3 within the CD34+
MPP population (Figure 1D). In agreement with the report
by Adolfsson et al., only rare LMPPs displayed MegE dif-
ferentiation (Figure 3A), suggesting that the vast majority
of LMPPs should have committed to the GM and lymphoid
lineages. The rare MegE potential of LMPPs could be due
to a small number of multipotent cells resides within the
LMPP definition. In contrast, the PU.1+Sca-1lo GMLP
constitutes 40% of the LMPP and appears to be more
strictly committed to the GM/lymphoid lineage (Figure 4).
Furthermore, 20% of LMPPs have activated RAG1 tran-
scription (Figure 1C), sufficing the ELP definition (Igarashi
et al., 2002). Only a fraction of ELPs possess GM potential
but lack MegE potential (Figure S1A), while the majority of
ELPs express a high level of PU.1 mRNA and a low level of.
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The Earliest Hematopoietic Stem Cell CommitmentSca-1 (Y.A. and K.A., unpublished data), suggesting that
at least a fraction of ELPs should be included in the
PU.1+Sca-1lo GMLP. Accordingly, a series of GM/lym-
phoid progenitors such as the LMPP, the PU.1+Sca-1lo
GMLP, and the RAG1+ ELP exist within the MPP fraction
expressing Flt3. Considering the lineage potential of
each population, they may represent continuous steps
for HSCs to differentiate into the lymphoid lineage where
cells progressively lose MegE and then GM potential (Aka-
shi et al., 2005).
It is important to note that the newly identified PU.1+
Sca-1lo GMLP differentiated exclusively into CLPs (Kondo
et al., 1997) and GMPs, whereas the GATA-1+Sca-1lo CMP
gave rise to the original Sca-1 CMPs (Akashi et al., 2000),
which is a precursor for both GMPs and MEPs. Further-
more, the PU.1+Sca-1lo GMLP has potent GM and lym-
phoid reconstitution activity (Figure 3), and the GATA-
1+Sca-1lo CMP had greater expansion potential to give
rise to erythrocytes and GM cells as compared to the orig-
inal Sca-1 CMP in vivo (Figure 5B). Since the PU.1+
Sca-1lo GMLP and the GATA-1+Sca-1lo CMP populations
do not overlap (Figures 1A and 1B), our data provide formal
evidence that the GM lineage could develop via two inde-
pendent pathways initiating from each of these progenitor
populations (Figure 7). This evidence strongly suggests
that hematolymphoid lineage commitment has already ini-
tiated within the LSK MPP fraction. It should be critical to
estimate the relative contribution of the PU.1+Sca-1lo
GMLP and the GATA-1+Sca-1lo CMP toward GM lineage
development in parallel. In our system, however, such
analysis is currently difficult, since the PU.1GFP/+ mouse
lacks one allele of PU.1 that causes a slight decrease in
the number of GM cells in vivo (Iwasaki et al., 2005b).
The successful separation of functionally distinct pro-
genitor populations in early hematopoiesis by PU.1 or
GATA-1 reporters suggests that early lineage commit-
ment is organized at least by the antagonistic interplay
of lineage-instructive signals. In line with the ‘‘priming’’
concept (Enver and Greaves, 1998; Iwasaki and Akashi,
2007), the original CMP coexpresses a low level of GM-
and MegE-related genes including PU.1 and GATA-1 at
the single-cell level (Miyamoto et al., 2002). PU.1 is ex-
pressed at a low level in CD34 LT-HSCs and CD34+
MPPs to play a critical role in their maintenance in vivo
(Iwasaki et al., 2005b), continues to be expressed at the
CMP and CLP stages (Iwasaki et al., 2005b; Miyamoto
et al., 2002), and is indispensable for their development
(Iwasaki et al., 2005b). In contrast, GATA-1 is not ex-
pressed in CD34 LT-HSCs or the vast majority of
CD34+ MPPs (Miyamoto et al., 2002) (Figures 1B and
2A). Thus, the slight upregulation of GATA-1 at the MPP
stage may result in the coexpression of PU.1 and GATA-
1 at the single-cell level to form the competitive transcrip-
tional regulatory circuit for GM versus MegE lineage fate
decision, which might be required to maintain the CMP
function (Iwasaki and Akashi, 2007) (Figure 7). In turn,
the upregulation of PU.1 at the MPP stage up to a high
level may suppress GATA-1 transcription, excluding the
MegE potential to generate GMLPs. Collectively, the tim-Celling (Iwasaki et al., 2006) and the level (DeKoter and Singh,
2000; Kulessa et al., 1995) of PU.1 and GATA-1 expres-
sion might be critical in organizing the early hematopoietic
lineage fate decision (Figure 7).
Prospective isolation strategy has been largely depen-
dent upon differences in cell surface markers that corre-
late with lineage commitment. To separate a particular
population, one needs to draw lines between populations
of different expression levels for each antigen, whereas
the change in the level of antigen expression in cells
should occur in a continuum manner. Setting the standard
for each gate is currently difficult, which could compro-
mise accurate comparisons of data between laboratories
(Akashi et al., 2005). Lineage tracing by utilizing transcrip-
tion factor reporters should be a significant addition for fu-
ture improvement of purification of cells with functional ho-
mogeneity. For example, we originally separated CMPs
within the LinSca-1c-Kit+ fraction based upon the ex-
pression pattern of CD34 and FcgRII/III (Akashi et al.,
2000). Interestingly, both PU.1+Sca-1lo GMLPs and
GATA-1+Sca-1lo CMPs possess the CD34 and FcgRII/III
profile indistinguishable to those in the original Sca-1
CMPs (Figure S1C). Since their discrimination on FACS
in the conventional staining protocol should rely only on
the level of Sca-1, both the PU.1+Sca-1lo GMLP and the
GATA-1+Sca-1lo CMP could fall into the original Sca-1
CMP gate. This could explain the heterogeneity of the orig-
inal CMP (Karsunky et al., 2003; Nutt et al., 2005): the orig-
inal CMP possesses weak B cell potential (Akashi et al.,
2000) that is found exclusively in its Flt3+ fraction (Kar-
sunky et al., 2003). The ‘‘Flt3+ CMPs’’ with lymphoid po-
tential could be ascribed to PU.1+Sca-1lo GMLP (Flt3+)
that fell into the Sca-1 gate. In fact, the Flt3+ CMP pos-
sessed a higher level (Nutt et al., 2005) and copy number
(Warren et al., 2006) of PU.1 mRNA as compared to the
‘‘Flt3 CMP.’’ Given the potent myeloerythroid activity
observed in the GATA-1+Sca-1lo CMP as compared to
the original Sca-1 CMP, we should now redefine that
the main CMP activity resides in Sca-1loGATA-1+ CMP
(Figure 7). However, to purify the Sca-1lo CMP in normal
mice, we need to identify an additional Sca-1lo CMP-
specific antigen that can replace the GATA-1 reporter.
In summary, tracking hematopoietic development utiliz-
ing reporters for lineage-instructive transcription factors
provided us with a high-resolution map within the LSK
HSC population. The upregulation of GATA-1 or PU.1 at
the previously defined MPP stage results in generation
of the functional CMP or the GMLP with potent expansion
potential in vivo. These data reasonably reconcile current
controversies including the issue of myeloerythroid versus
lymphoid divergence (Akashi et al., 2005; Hock and Orkin,
2005; Iwasaki and Akashi, 2007) and of possible heteroge-
neity of the LMPP (Adolfsson et al., 2005) and of the orig-
inal CMP (Akashi et al., 2000) purified by conventional pro-
tocols. Based on the mutually exclusive interplay between
PU.1 and GATA-1, HSCs might be able to lose lymphoid
potential to give rise to the CMP and could also discard
MegE potential to generate the GMLP during early hema-
topoietic development. These early LSK progenitors areStem Cell 1, 416–427, October 2007 ª2007 Elsevier Inc. 425
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including the original CMP (Akashi et al., 2000) and CLP
(Kondo et al., 1997). Prospective isolation of current and
yet-to-be discovered stem and progenitor cell subsets
by a lineage-instructive signal-based approach should
thus be useful to create high-resolution maps for all blood
cell lineages in future studies.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J (Ly5.2) and congenic B6.SJL-Ptprca Pepcb/BoyJ (Ly5.1)
mice were purchased from Jackson Laboratory (Bar Harbor, ME).
Rag2-deficient mice (B6.SJL[129S6]-Ptprca/BoyCrTac-Rag2tm1Fwa
N10) were purchased from Taconic Farms. PU.1GFP/+ knockin (Back
et al., 2004), GATA-1-GFP transgenic (Iwasaki et al., 2005a),RAG1+/GFP
knockin (Igarashi et al., 2002) (kindly provided by Dr. Sakaguchi), and
gpIIb+/YFP knockin (Schulze et al., 2006) mouse lines were bred and
maintained in the Research Animal Facility at the Dana-Farber Cancer
Institute in accordance with the guidelines.
Antibodies, Cell Staining, and Sorting
Sorting of LSK subfractions was accomplished by staining bone
marrow cells with biotinylated anti-CD34 (RAM34) (PharMingen, San
Diego, CA) monoclonal antibodies, PE-conjugated anti-Flt3 (A2F10),
APC-conjugated anti-Sca-1 (D7), APC-Cy7-conjugated anti-c-Kit
(2B8), and PE-Cy5-conjugated rat antibodies specific for IL-7Ra
(A7R34) (eBioscience, San Diego, CA) and the following lineage
markers: CD3 (CT-CD3), CD4 (RM4-5), CD8 (5H10), B220 (6B2), Gr-
1 (8C5), and CD19 (6D5) (Caltag, Burlingame, CA), followed by avi-
din-PE-Cy7 (eBioscience, San Diego, CA). For myeloid progenitors
sorting, bone marrow cells were stained with biotinylated anti-CD34
(RAM34) monoclonal antibodies, PE-conjugated anti-FcgRII/III (93)
(eBioscience), APC-conjugated anti-Sca-1 (D7), APC-Cy7-conjugated
anti-c-Kit (2B8), and PE-Cy5-conjugated rat antibodies specific for
IL-7Ra (A7R34) and the lineage markers described above, followed
by avidin-PE-Cy7. Myeloid progenitors were sorted as IL-
7RaLinSca-1c-Kit+CD34+FcgRII/IIIlo (CMPs), IL-7RaLinSca-
1c-Kit+CD34+FcgRII/IIIhi (GMPs), and IL-7RaLinSca-1c-
Kit+CD34FcgRII/IIIlo (MEPs) as described previously (Akashi et al.,
2000). CLP staining was performed by using PE-conjugated anti-IL-
7Ra (A7R34) (eBioscience), APC-conjugated anti-Sca-1 (D7), APC-
Cy7-conjugated anti-c-Kit (2B8), and PE-Cy5-conjugated rat anti-
bodies specific for the lineage markers described above. CLP was de-
fined as a LinIL-7Ra+Sca-1loc-Kitlo population (Kondo et al., 1997). All
of these stem and progenitor cells were double sorted using BD FAC-
SAria cell-sorting system (BD Biosciences, San Jose, CA).
In Vitro Assays to Evaluate Lineage Potential
To test myeloerythroid potential, single cells were sorted directly into
60-well Terasaki plates with IMDM containing 20% fetal bovine serum
(FBS). Cytokines such as murine Slf (20 ng/ml), IL-3 (20 ng/ml), IL-11
(10 ng/ml), GM-CSF (10 ng/ml), Epo (4 unit/ml), and Tpo (10 ng/ml)
(R&D Systems, Minneapolis, MN) were added at the initiation of cul-
tures. Cell components of each cultures were determined morpholog-
ically and cytochemically by May-Giemsa staining. To evaluate B cell
differentiation potential, cells were sorted onto irradiated (2500 cGy)
OP9 stromal layers in the presence of IL-7 (20 ng/ml) and Slf (20 ng/
ml). To test T cell differentiation potential, cells were sorted onto irradi-
ated OP9-DL1 stromal layers in the presence of IL-7 (5 ng/ml) and Flt3L
(5 ng/ml) (Schmitt and Zuniga-Pflucker, 2002). To evaluate the lineal re-
lationships among LSKs, CMPs, GMPs, MEPs, and CLPs, 10,000 cells
of each population were cultured for 40 hr on OP9 stromal layers in 24-
well plates with IMDM containing 10% FBS in the presence of Slf (10
ng/ml). All cultures were incubated at 37C in a humidified chamber
under 5% CO2.426 Cell Stem Cell 1, 416–427, October 2007 ª2007 Elsevier IncIn Vivo Reconstitution Assays
Five hundred cells of each population (Ly5.2) were intravenously trans-
planted into congenic mice (Ly5.1) after lethal (950 rad) irradiation. In
some experiments, 300 LSKs purified from recipient-type (Ly5.1)
mice or Rag2-deficient mice (Ly5.1) were cotransplanted to rescue
transplanted mice.
Analysis of Gene Expression from Total RNA
Total RNA extracted from 200 cells each of target populations was
subjected to real-time PCR analyses as described previously (Iwasaki
et al., 2005a). Primer and probe sequences used in this assay are des-
ribed in Table S1.
Supplemental Data
Supplemental Data include one figure and one table and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/
1/4/416/DC1/.
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